TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,343,894
|
2,358,921
|
2,161,066 |
| Financial expenses |
87,027
|
95,378
|
79,520 |
| Earnings before taxes |
437,735
|
-2,493,256
|
358,841 |
| EBITDA |
734,537
|
750,260
|
701,645 |
| Total assets |
11,330,445
|
10,967,773
|
13,732,861 |
| Current assets |
1,530,773
|
1,285,585
|
1,051,131 |
| Current liabilities |
457,218
|
374,123
|
414,973 |
| Equity capital |
8,858,608
|
8,545,043
|
11,183,552 |
| - share capital |
18,185
|
18,807
|
18,711 |
| Employees (average) |
1,082
|
1,084
|
1,117 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
78.2%
|
77.9%
|
81.4% |
| Turnover per employee |
2,166
|
2,176
|
1,935 |
| Profit as a percentage of turnover |
18.7%
|
-105.7%
|
16.6% |
| Return on assets (ROA) |
4.6%
|
-21.9%
|
3.2% |
| Current ratio |
334.8%
|
343.6%
|
253.3% |
| Return on equity (ROE) |
4.9%
|
-29.2%
|
3.2% |
| Change turnover |
62,997
|
186,726
|
1,037,897 |
| Change turnover % |
3%
|
9%
|
92% |
| Chg. No. of employees |
-2
|
-33
|
639 |
| Chg. No. of employees % |
0%
|
-3%
|
134% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.